Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B W van Rhijn

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer|September 11, 2001
Microsatellite analysis--DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma: a phase II trialB W van Rhijn, I Lurkin, W J Kirkels, et al.
Cancer Research|March 14, 2001
The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rateB W van Rhijn, I Lurkin, F Radvanyi, et al.
Urology|October 6, 2000
Consecutive quantitative cytology in bladder cancerH G van der Poel, B W van Rhijn, P Peelen, et al.
Urology|March 4, 2000
Presence of carcinoma in situ and high 2C-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk QuanticytB W van Rhijn, H G van der Poel, M E Boon, et al.
World Journal of Urology|August 10, 2012
Differences in histopathological evaluation of standard lymph node dissections result in differences in nodal count but not in survivalL S Mertens, R P Meijer, E van Werkhoven, et al.
The Journal of Urology|December 20, 2011
Standard lymph node dissection for bladder cancer: significant variability in the number of reported lymph nodesR P Meijer, R P P Meijer, C J M Nunnink, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 5, 2013
Response to induction chemotherapy and surgery in non-organ confined bladder cancer: a single institution experienceR P Meijer, J A Nieuwenhuijzen, W Meinhardt, et al.
Scientific Reports|July 19, 2017
Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder CancerK M Patel, K E van der Vos, C G Smith, et al.
European Urology Focus|August 11, 2020
Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International ConsortiumMaria Carmen Mir, Michele Marchioni, Homi Zargar, et al.
World Journal of Urology|June 9, 2018
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomyN Vasdev, H Zargar, J P Noël, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer|September 11, 2001
Microsatellite analysis--DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma: a phase II trialB W van Rhijn, I Lurkin, W J Kirkels, et al.
Cancer Research|March 14, 2001
The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rateB W van Rhijn, I Lurkin, F Radvanyi, et al.
Urology|October 6, 2000
Consecutive quantitative cytology in bladder cancerH G van der Poel, B W van Rhijn, P Peelen, et al.
Urology|March 4, 2000
Presence of carcinoma in situ and high 2C-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk QuanticytB W van Rhijn, H G van der Poel, M E Boon, et al.
World Journal of Urology|August 10, 2012
Differences in histopathological evaluation of standard lymph node dissections result in differences in nodal count but not in survivalL S Mertens, R P Meijer, E van Werkhoven, et al.
The Journal of Urology|December 20, 2011
Standard lymph node dissection for bladder cancer: significant variability in the number of reported lymph nodesR P Meijer, R P P Meijer, C J M Nunnink, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 5, 2013
Response to induction chemotherapy and surgery in non-organ confined bladder cancer: a single institution experienceR P Meijer, J A Nieuwenhuijzen, W Meinhardt, et al.
Scientific Reports|July 19, 2017
Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder CancerK M Patel, K E van der Vos, C G Smith, et al.
European Urology Focus|August 11, 2020
Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International ConsortiumMaria Carmen Mir, Michele Marchioni, Homi Zargar, et al.
World Journal of Urology|June 9, 2018
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomyN Vasdev, H Zargar, J P Noël, et al.
Pageof 1